Literature DB >> 9102182

Ser447stop mutation in lipoprotein lipase is associated with elevated HDL cholesterol levels in normolipidemic males.

J A Kuivenhoven1, B E Groenemeyer, J M Boer, P W Reymer, R Berghuis, T Bruin, H Jansen, J C Seidell, J J Kastelein.   

Abstract

This report describes the association between a frequent mutation in the lipoprotein lipase (LPL) gene and HDL cholesterol levels. It concerns a previously described defect that predicts a premature truncation of the LPL protein (447stop). We determined the frequency of this mutation in three groups of healthy men with low-, middle-, and upper-decile HDL cholesterol. The number of carriers of the 447stop allele was significantly greater in the high HDL group than in either the groups with normal HDL (P = .017) or low HDL (P < .0001). Additional functional assessment of this mutation did not reveal distinct differences between wild-type LPL and the LPL447stop protein. In conclusion, we have shown that the 447stop mutation is associated with increased HDL cholesterol in healthy Dutch males, although the underlying mechanism remains to be elucidated. Because HDL cholesterol is strongly inversely related with CAD, this genotype might be of potential benefit to its carriers.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9102182     DOI: 10.1161/01.atv.17.3.595

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  13 in total

1.  A multilocus genotyping assay for candidate markers of cardiovascular disease risk.

Authors:  S Cheng; M A Grow; C Pallaud; W Klitz; H A Erlich; S Visvikis; J J Chen; C R Pullinger; M J Malloy; G Siest; J P Kane
Journal:  Genome Res       Date:  1999-10       Impact factor: 9.043

2.  Variants for HDL-C, LDL-C, and triglycerides identified from admixture mapping and fine-mapping analysis in African American families.

Authors:  Priya B Shetty; Hua Tang; Tao Feng; Bamidele Tayo; Alanna C Morrison; Sharon L R Kardia; Craig L Hanis; Donna K Arnett; Steven C Hunt; Eric Boerwinkle; Dabeeru C Rao; Richard S Cooper; Neil Risch; Xiaofeng Zhu
Journal:  Circ Cardiovasc Genet       Date:  2014-12-31

Review 3.  Human genetics of variation in high-density lipoprotein cholesterol.

Authors:  Atif Qasim; Daniel J Rader
Journal:  Curr Atheroscler Rep       Date:  2006-05       Impact factor: 5.113

4.  Study of Common Genetic Variant S447X in Lipoprotein Lipase and Its Association with Lipids and Lipoproteins in Type 2 Diabetic Patients.

Authors:  A A Momin; M P Bankar; G M Bhoite
Journal:  Indian J Clin Biochem       Date:  2015-10-13

5.  Molecular genetics of myocardial infarction.

Authors:  Yoshiji Yamada; Sahoko Ichihara; Tamotsu Nishida
Journal:  Genomic Med       Date:  2008-08-14

6.  Genetic variation in the OX40L/OX40 system and plasma lipid and lipoprotein levels in a Chinese hypertriglyceridemic population.

Authors:  Rui Liu; Yan Qiao; Yu Liu; Xian Li; Yucheng Chen; Ou Qiang; Huai Bai
Journal:  Genet Test Mol Biomarkers       Date:  2012-12-07

7.  Functional significance of lipoprotein lipase HindIII polymorphism associated with the risk of coronary artery disease.

Authors:  Qi Chen; Hamid Razzaghi; F Yesim Demirci; M Ilyas Kamboh
Journal:  Atherosclerosis       Date:  2008-02-01       Impact factor: 5.162

8.  The lipoprotein lipase gene in combined hyperlipidemia: evidence of a protective allele depletion.

Authors:  Shu-Fen Wung; Medha V Kulkarni; Clive R Pullinger; Mary J Malloy; John P Kane; Bradley E Aouizerat
Journal:  Lipids Health Dis       Date:  2006-07-05       Impact factor: 3.876

9.  Sex-associated effect of CETP and LPL polymorphisms on postprandial lipids in familial hypercholesterolaemia.

Authors:  Katherine K Anagnostopoulou; Genovefa D Kolovou; Peggy M Kostakou; Constantinos Mihas; Georgios Hatzigeorgiou; Christina Marvaki; Dimitrios Degiannis; Dimitri P Mikhailidis; Dennis V Cokkinos
Journal:  Lipids Health Dis       Date:  2009-06-26       Impact factor: 3.876

10.  Current clinical evidence on pioglitazone pharmacogenomics.

Authors:  Marina Kawaguchi-Suzuki; Reginald F Frye
Journal:  Front Pharmacol       Date:  2013-11-26       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.